Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity

Lihui Wang(Shenyang Pharmaceutical University), Chunfu Wu(Shenyang Pharmaceutical University)
Cell Death and Disease
April 13, 2017
Cited by 134


Related Papers